Navigation Links
DMP for diabetes type 2: Current guidelines indicate some need for revision
Date:1/3/2012

On 3 January 2012, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with diabetes mellitus type 2. The aim of the report is to identify those recommendations from current guidelines of high methodological quality that may be relevant for the planned revision of the corresponding disease management programme (DMP). According to the results of the report, there is no compelling need for revision of any part of the DMP. However, IQWiG identified various aspects that could be supplemented and specified.

Evidence was documented in detail

One of the responsibilities of IQWiG specified by law (Social Code Book V) is to develop and issue recommendations for DMPs. In the commission now completed, which was awarded by the Federal Joint Committee (G-BA), IQWiG systematically searched for new guidelines, assessed their methodological quality, and extracted relevant recommendations on the diagnosis and treatment of diabetes mellitus type 2, its accompanying diseases and late complications, as well as on the cooperation of health care sectors. In addition, the Institute documented how highly the guideline authors graded the robustness of the recommendations. However, the sources of the recommendations were not examined again; this is where IQWiG's guideline appraisals and benefit assessments differ.

No contradictions between the DMP and current recommendations

A total of 35 German and international guidelines containing recommendations on the treatment of diabetes type 2 were included. As the analysis showed, the recommendations are, by and large, consistent with the specifications of the DMP. No contradictions in content concerning the DMP requirements were found. The Director of IQWiG, Professor Dr med. Jrgen Windeler, stresses that "patients with diabetes mellitus type 2 can thus be sure that the current DMP is consistent with the current status of medical knowledge on all main points."

Some potential additional recommendations identified for the DMP

However, in these guidelines, recommendations were found on a total of 8 subject areas where, after examination and discussion, the need was identified to update and supplement the German DMP for diabetes mellitus type 2, or at least to discuss such measures.

For example, some guidelines recommend additional medication. Among other things, this applies to the topical use of isosorbide dinitrate and capsaicin spray for treatment of painful diabetic neuropathy. For the prevention and treatment of diabetic foot syndrome, guidelines recommend examining the condition of the blood vessels by means of the ankle-arm index.

It is first of all the Institute's responsibility to identify differences between guideline recommendations and the DMP. The Federal Joint Committee then examines whether these differences should actually lead to a revision of the DMP for diabetes mellitus type 2.


'/>"/>
Contact: Anna-Sabine Ernst
presse@iqwig.de
49-221-356-850
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Related medicine news :

1. Gestational diabetes and low socioeconomic status linked with increased risk of ADHD in offspring
2. Obesity, Diabetes Pose 1-2 Threat to Young Americans
3. Dr. Andrew Advani receives Diabetes Innovation Award
4. Holiday Travel Tips for People With Diabetes
5. Hepatitis B Vaccine Recommended for Adults With Diabetes
6. Driving Isnt An Issue for Most People With Diabetes
7. Diabetes, Obesity After 60 May Drive Up Breast Cancer Risk
8. Rotating night shift work linked to increased risk of Type 2 diabetes in women
9. Rotating Shift Work May Boost Womens Diabetes Risk
10. Vitamin D Levels Tied to Diabetes Risk in Obese Kids
11. Risk for Dementia Rises When Diabetes, Depression Meet: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... TX (PRWEB) , ... October 13, 2017 , ... ... planning agency serving communities in the greater Dallas, Miami, and Raleigh regions, is ... boy fighting to overcome a rare and deadly chromosome abnormality. , After struggling ...
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected Warren ... James C. Puffer upon his retirement. Dr. Newton will serve in the position of ... end of 2018. Upon assuming the role of President and CEO on January 1, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of ... ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership in ... It also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... Oct. 10, 2017   West Pharmaceutical Services, Inc. ... for injectable drug administration, today shared the results of ... for improving the intradermal administration of polio vaccines. The ... Summit in May 2017 by Dr. Ondrej Mach ... World Health Organization (WHO), and recently published in the ...
(Date:10/4/2017)... , Oct. 4, 2017 ... single-use, self-contained, illuminating medical devices, today announced regulatory ... Health Surveillance Agency (or Agência Nacional de Vigilância ... first single-use, cordless surgical retractor with integrated LED ... optimal access, illumination and exposure of a tissue ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
Breaking Medicine Technology: